14 August 2024
Clifford Chance advises Keymed Biosciences Inc. on out-licensing transaction with Belenos Biosciences
Advising firms
Deal team
16 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Yang Yi Lead | Clifford Chance | Partner | M&A, antitrust, intellectual property and equity investment | Shanghai |
| Bai Yong | Clifford Chance | Partner | Not stated | Beijing |
| Dayu Man | Clifford Chance | Counsel | Not stated | Beijing |
| Carolin Kemmner | Clifford Chance | Counsel | Not stated | Düsseldorf |
| Annabel Joschko | Clifford Chance | Associate | Not stated | Düsseldorf |
| Yuling Geng | Clifford Chance | Counsel | Not stated | Hong Kong |
| Michael Yan | Clifford Chance | Senior associate | Not stated | Hong Kong |
| Andrew Epstein | Clifford Chance | Partner | Not stated | New York |
| Jason Parsont | Clifford Chance | Partner | Not stated | New York |
| Matthew Warner | Clifford Chance | Partner | healthcare and US investment | New York |
| Daryl Fairbairn | Clifford Chance | Counsel | Not stated | New York |
| Lauren Rackow | Clifford Chance | Counsel | Not stated | New York |
| Vicki Ye | Clifford Chance | Associate | Not stated | New York |
| Brian Concklin | Clifford Chance | Partner | Not stated | Washington, D.C. |
| Renee Latour | Clifford Chance | Partner | Not stated | Washington, D.C. |
| Elyssa Wenzel | Clifford Chance | Associate | Not stated | Washington, D.C. |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Keymed Biosciences (Chengdu) Co., Ltd.Sell-side
- Counterparties
- Belenos Biosciences, Inc. (Buy-side)